Reference
Dong D, et al. Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report. Oncologist 25: e1720-e1724, No. 11, Nov 2020. Available from: URL: http://doi.org/10.1634/theoncologist.2019-0609
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1860, 50 (2021). https://doi.org/10.1007/s40278-021-97505-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-97505-7